ITC Launches 337 Case Over Lilly's Gemzar Patent
The U.S. International Trade Commission on Thursday launched an investigation to determine if Hospira Inc. and affiliated pharmaceutical suppliers are importing generic versions of Eli Lilly & Co.'s cancer drug Gemzar....To view the full article, register now.
Already a subscriber? Click here to view full article